82 related articles for article (PubMed ID: 17556530)
1. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with Tat.
Sun Q; Matta H; Chaudhary PM
Retrovirology; 2005 Feb; 2():9. PubMed ID: 15713234
[TBL] [Abstract][Full Text] [Related]
3. Genetic Variability of Long Terminal Repeat Region between HIV-2 Groups Impacts Transcriptional Activity.
Le Hingrat Q; Visseaux B; Bertine M; Chauveau L; Schwartz O; Collin F; Damond F; Matheron S; Descamps D; Charpentier C
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915276
[TBL] [Abstract][Full Text] [Related]
4. Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription.
Estable MC; Bell B; Hirst M; Sadowski I
J Virol; 1998 Aug; 72(8):6465-74. PubMed ID: 9658089
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 reactivation by a telomerase-derived peptide in a HSP90-dependent manner.
Kim H; Choi MS; Inn KS; Kim BJ
Sci Rep; 2016 Jul; 6():28896. PubMed ID: 27363520
[TBL] [Abstract][Full Text] [Related]
6. Analysis of 2-LTR circle junctions of viral DNA in infected cells.
Mandal D; Prasad VR
Methods Mol Biol; 2009; 485():73-85. PubMed ID: 19020819
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of HIV by Mycobacterium tuberculosis in human monocytes.
Toossi Z; Xia L; Wu M; Salvekar A
Clin Exp Immunol; 1999 Aug; 117(2):324-30. PubMed ID: 10444265
[TBL] [Abstract][Full Text] [Related]
8. NFAT5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat site.
Ranjbar S; Tsytsykova AV; Lee SK; Rajsbaum R; Falvo JV; Lieberman J; Shankar P; Goldfeld AE
PLoS Pathog; 2006 Dec; 2(12):e130. PubMed ID: 17173480
[TBL] [Abstract][Full Text] [Related]
9. A unified classification system for HIV-1 5' long terminal repeats.
Guo X; Yu D; Liu M; Li H; Chen M; Wang X; Zhai X; Zhang B; Wang Y; Yang C; Wang C; Liu Y; Han J; Wang X; Li J; Jia L; Li L
PLoS One; 2024; 19(5):e0301809. PubMed ID: 38696412
[TBL] [Abstract][Full Text] [Related]
10. Influencing factors and adverse outcomes of virologic rebound states in anti-retroviral-treated individuals with HIV infection.
Yuan D; Li M; Zhou Y; Shi L; Lu J; Fu G; Wang B
J Virus Erad; 2023 Mar; 9(1):100320. PubMed ID: 37008574
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D signaling inhibits HBV activity by directly targeting the HBV core promoter.
Ahluwalia S; Choudhary D; Tyagi P; Kumar V; Vivekanandan P
J Biol Chem; 2021 Oct; 297(4):101233. PubMed ID: 34562448
[TBL] [Abstract][Full Text] [Related]
12. Hidden in plain sight: The effects of BCG vaccination in the COVID-19 pandemic.
Toraih EA; Sedhom JA; Dokunmu TM; Hussein MH; Ruiz EML; Muthusamy K; Zerfaoui M; Kandil E
J Med Virol; 2021 Apr; 93(4):1950-1966. PubMed ID: 33289122
[TBL] [Abstract][Full Text] [Related]
13. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity.
Proal A; Marshall T
Front Pediatr; 2018; 6():373. PubMed ID: 30564562
[TBL] [Abstract][Full Text] [Related]
14. Counter-intuitive plasma vitamin D and zinc status in HIV-1-infected adults with persistent low-level viraemia after treatment initiation: a pilot case-control study.
Melliez H; Duhamel A; Robineau O; Bocket L; Kim I; Sauser E; Loiseleur F; Viget N; Pasquet A; Senneville E; Seguy D
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2085-2092. PubMed ID: 28647858
[TBL] [Abstract][Full Text] [Related]
15. HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.
Saleh S; Lu HK; Evans V; Harisson D; Zhou J; Jaworowski A; Sallmann G; Cheong KY; Mota TM; Tennakoon S; Angelovich TA; Anderson J; Harman A; Cunningham A; Gray L; Churchill M; Mak J; Drummer H; Vatakis DN; Lewin SR; Cameron PU
Retrovirology; 2016 Jul; 13(1):49. PubMed ID: 27459960
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors for the Vitamin D Receptor-Coregulator Interaction.
Teske KA; Yu O; Arnold LA
Vitam Horm; 2016; 100():45-82. PubMed ID: 26827948
[TBL] [Abstract][Full Text] [Related]
17. High transcript levels of vitamin D receptor are correlated with higher mRNA expression of human beta defensins and IL-10 in mucosa of HIV-1-exposed seronegative individuals.
Aguilar-Jiménez W; Zapata W; Caruz A; Rugeles MT
PLoS One; 2013; 8(12):e82717. PubMed ID: 24349345
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial implications of vitamin D.
Youssef DA; Miller CW; El-Abbassi AM; Cutchins DC; Cutchins C; Grant WB; Peiris AN
Dermatoendocrinol; 2011 Oct; 3(4):220-9. PubMed ID: 22259647
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa.
Martineau AR; Nhamoyebonde S; Oni T; Rangaka MX; Marais S; Bangani N; Tsekela R; Bashe L; de Azevedo V; Caldwell J; Venton TR; Timms PM; Wilkinson KA; Wilkinson RJ
Proc Natl Acad Sci U S A; 2011 Nov; 108(47):19013-7. PubMed ID: 22025704
[TBL] [Abstract][Full Text] [Related]
20. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.
Kajaste-Rudnitski A; Marelli SS; Pultrone C; Pertel T; Uchil PD; Mechti N; Mothes W; Poli G; Luban J; Vicenzi E
J Virol; 2011 May; 85(10):5183-96. PubMed ID: 21345949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
